MRVL COO reports RSU vesting: 11,362 shares; 5,635 withheld

Marvell Technology (MRVL) insider Christopher R. Koopmans, President and COO, reported routine equity transactions on 10/15/2025.

Rhea-AI Filing Summary

Marvell Technology (MRVL) insider Christopher R. Koopmans, President and COO, reported routine equity transactions on 10/15/2025. Restricted Stock Units vested and were settled into 11,362 shares of Common Stock at $0, held indirectly by the Koopmans Family Trust. To cover tax withholding from the vesting, the trust surrendered 5,635 shares at a price of $88.89 per share.

Following these transactions, the trust beneficially owned 110,552 shares. The filing notes remaining RSU tranches scheduled to vest on specified dates from January 15, 2026 through April 15, 2028.

Insider Trade Summary

11,362 shares exercised/converted

Exercise 9 txns

Insider Koopmans Chris

Role President and COO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	4,497	$0.00	$0.00
Exercise	Restricted Stock Units	2,788	$0.00	$0.00
Exercise	Restricted Stock Units	4,077	$0.00	$0.00
Exercise	Common Stock	4,497	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,230	$88.89	$198K
Exercise	Common Stock	2,788	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,383	$88.89	$123K
Exercise	Common Stock	4,077	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	2,022	$88.89	$180K

Holdings After Transaction: Restricted Stock Units — 66,490 contracts (Direct); Common Stock — 110,552 shares (Indirect, By Trust)

Footnotes (6)

1. F1. Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.
2. F2. Surrender of shares in payment of tax withholding due as a result of the vesting of Restricted Stock Units.
3. F3. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock of Marvell Technology, Inc. upon vesting.
4. F4. The remaining Restricted Stock Units shall vest on January 15, 2026 and April 15, 2026.
5. F5. The remaining Restricted Stock Units shall vest on January 15, 2026, April 15, 2026, July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027.
6. F6. The remaining Restricted Stock Units shall vest on January 15, 2026, April 15, 2026, July 15, 2026, October 15, 2026, January 15, 2027, April 15, 2027, July 15, 2027, October 15, 2027, January 15, 2028 and April 15, 2028.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MRVL’s COO report on Form 4?

Christopher R. Koopmans reported RSU vesting into 11,362 shares and tax-withholding surrender of 5,635 shares on 10/15/2025.

What price was used for the tax-withholding share surrender?

Shares were surrendered at $88.89 per share to cover tax withholding.

How many MRVL shares does the reporting person own after the transactions?

Beneficial ownership is 110,552 shares, held indirectly by the Koopmans Family Trust.

Were the acquired shares purchased on the market?

No. The 11,362 shares were issued upon RSU vesting at a price of $0.

How were the dispositions classified in the filing?

They were coded F, indicating surrender of shares to satisfy tax withholding due to RSU vesting.

What future vesting dates are noted for remaining RSUs?

Remaining RSUs vest on dates from January 15, 2026 through April 15, 2028 as scheduled.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/17/2025 - 03:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koopmans Chris

(Last) (First) (Middle)

5488 MARVELL LANE

(Street)

SANTA CLARA CA 95054

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Marvell Technology, Inc. [ MRVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and COO

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2025		M		4,497	A	$0	109,322	I	By Trust(1)
Common Stock	10/15/2025		F(2)		2,230	D	$88.89	107,092	I	By Trust(1)
Common Stock	10/15/2025		M		2,788	A	$0	109,880	I	By Trust(1)
Common Stock	10/15/2025		F(2)		1,383	D	$88.89	108,497	I	By Trust(1)
Common Stock	10/15/2025		M		4,077	A	$0	112,574	I	By Trust(1)
Common Stock	10/15/2025		F(2)		2,022	D	$88.89	110,552	I	By Trust(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	10/15/2025		M			4,497	(4)	(4)	Common Stock	4,497	$0	8,995	D
Restricted Stock Units	(3)	10/15/2025		M			2,788	(5)	(5)	Common Stock	2,788	$0	16,725	D
Restricted Stock Units	(3)	10/15/2025		M			4,077	(6)	(6)	Common Stock	4,077	$0	40,770	D

Explanation of Responses:

1. Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

2. Surrender of shares in payment of tax withholding due as a result of the vesting of Restricted Stock Units.

3. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock of Marvell Technology, Inc. upon vesting.

4. The remaining Restricted Stock Units shall vest on January 15, 2026 and April 15, 2026.

5. The remaining Restricted Stock Units shall vest on January 15, 2026, April 15, 2026, July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027.

6. The remaining Restricted Stock Units shall vest on January 15, 2026, April 15, 2026, July 15, 2026, October 15, 2026, January 15, 2027, April 15, 2027, July 15, 2027, October 15, 2027, January 15, 2028 and April 15, 2028.

Remarks:

	Christopher Koopmans by Blair Walters as Attorney-in-Fact	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.